Viekira pak and Itching - a phase IV clinical study of FDA data
Summary:
Itching is reported as a side effect among people who take Viekira pak (dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Ribasphere, and have Hepatitis c.
The phase IV clinical study analyzes which people have Itching when taking Viekira pak. It is created by eHealthMe based on reports of 10,520 people who have side effects when taking Viekira pak from the FDA, and is updated regularly.
What is Viekira pak?
Viekira pak has active ingredients of dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir. eHealthMe is studying from 10,521 Viekira pak users. Check the latest studies of Viekira pak.
What is Itching?
Itching is found to be associated with 3,211 drugs and 4,538 conditions by eHealthMe. Check the latest studies of Itching.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
10,520 people reported to have side effects when taking Viekira pak.
Among them, 886 people (8.42%) have Itching.
Among these 886 people:
How long have people been on Viekira pak when they have Itching? *
What is the gender of people who have Itching when taking Viekira pak? *
What is the age of people who have Itching when taking Viekira pak? *
What are other drugs people take besides Viekira pak? *
What are other side effects people have besides Itching? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Viekira pak and have Itching?
- Check whether Itching is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Viekira pak:
- Viekira pak (10,521 reports)
Itching treatments and more:
- Itching (398,822 reports)
How severe was Itching and when was it recovered:
Expand to all the drugs that have ingredients of dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir:
- Itching and drugs with ingredients of dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir (913 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Viekira pak:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Itching:
- Itching (3,211 drugs)
Browse all the conditions that are associated with Itching:
- Itching (4,538 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir (the active ingredients of Viekira pak) and Viekira pak (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Migraine and drugs of ingredients of norethindrone - a second ago
- Lacosamide and Multiple-Drug Resistance for Men aged 60+ - 2 seconds ago
- Percocet and Cholelithiasis for Women aged 30-39 - 9 seconds ago
- Percocet and Gallstones for Women aged 30-39 - 9 seconds ago
- Type 2 Diabetes and drugs of ingredients of dapagliflozin propanediol; metformin hydrochloride - 10 seconds ago
- Proair Hfa and Sprintec drug interactions for women aged 20-29 - 10 seconds ago
- Diabetes Mellitus Non-Insulin-Dependent and drugs of ingredients of dapagliflozin propanediol; metformin hydrochloride - 11 seconds ago
- Omeprazole and Q10 drug interactions for women aged 20-29 - 11 seconds ago
- Drug interactions of Chondroitin and Vitamin C - 12 seconds ago
- Aplenzin vs. Adderall 30, side effect and effectiveness comparison - 13 seconds ago